Immature platelets in patients with acute coronary syndromes
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Summary: Platelets newly released from the bone marrow are RNA-containing and more haemostatically active than mature platelets. Immature platelets are reliably quantified by flow cytometry, and the immature platelet fraction (IPF) reflects platelet production and the rate of platelet turnover. It was the objective of this study to evaluate the presence of immature platelets in healthy subjects, patients with stable coronary artery disease (CAD) and patients with acute coronary syndromes. Flow cytometric determination of immature platelets was performed with an automated analyzer (Sysmex XE-2100) using RNA fluorescent dyes. IPF was determined in 420 individuals: 22 healthy subjects, 39 patients with stable CAD, 182 patients with unstable angina/ non-ST-segment elevation myocardial infarction (non-STEMI) and 177 patients with acute STEMI. The geometric mean [95% confidence interval] of IPF was 2.51 [2.04–3.10] in healthy subjects, 2.87 [2.45–3.36] in CAD patients, 2.93 [2.72–3.15] in the non-STEMI/unstable angina group and 3.71 [3.45–3.99] in patients with STEMI (ANOVA: p < 0.0001). This difference remained significant after adjusting for baseline characteristics (p = 0.0003). In active smokers, IPF was 18% higher than in non-smoking individuals (p = 0.007), and IPF was 16% higher in diabetics compared with non-diabetics (p = 0.060). In conclusion, the fraction of immature platelets is increased in acute coronary syndromes, especially in the acute phase of STEMI. Immature platelets with an increased haemostatic potential may contribute to coronary thrombus formation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased platelet clearance results in a reduced platelet life span and a relative preponderance of large, immature circulating platelets.34,35”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [35]
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Aspirin “resistance” and risk of cardiovascular morbidity: systematic review and meta-analysis
Krasopoulos, G., Brister, S. J., Beattie, W. S., & Buchanan, M. R. (2008) · BMJ · doi:10.1136/bmj.39430.529549.be · Cited by 708
Martin, J. F., Trowbridge, E. A., Salmon, G., & Plumb, J. (1983) · Thrombosis Research · doi:10.1016/0049-3848(83)90255-4 · Cited by 466
Snoep, J. D. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.15.1593 · Cited by 412
Thompson, C. B., Eaton, K. A., Princiotta, S. M., Rushin, C. A., & Valeri, C. R. (1982) · British Journal of Haematology · doi:10.1111/j.1365-2141.1982.tb01947.x · Cited by 375
Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia
Briggs, C., Kunka, S., Hart, D., Oguni, S., & Machin, S. J. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04987.x · Cited by 354
Ault, K. A., Rinder, H. M., Mitchell, J., Carmody, M. B., Vary, C. P. H., & Hillman, R. S. (1992) · American Journal of Clinical Pathology · doi:10.1093/ajcp/98.6.637 · Cited by 260
Variable Platelet Response to Aspirin and Clopidogrel in Atherothrombotic Disease
Maree, A. O., & Fitzgerald, D. J. (2007) · Circulation · doi:10.1161/circulationaha.106.675991 · Cited by 211
Changes in volume and density of platelets in myocardial infarction.
Martin, J. F., Plumb, J., Kilbey, R. S., & Kishk, Y. T. (1983) · BMJ · doi:10.1136/bmj.287.6390.456 · Cited by 201
Determinants of the interindividual variability in response to antiplatelet drugs
Rocca, B., & Patrono, C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01380.x · Cited by 89
Cited by
Items 101–200 of 202
Yahud, E., Schilo, T., Nevzorov, R., Asher, E., Bryk, G., Laish‐Farkash, A., & Lev, E. I. (2021) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.13499 · Cited by 13
“Chronic Heart Failure, n (%) 10 (20) 4 (8) 0.”
Pedersen, O. H., Larsen, M. L., Kristensen, S. D., Hvas, A., & Grove, E. L. (2017) · American Journal of Case Reports · doi:10.12659/ajcr.904148 · Cited by 13
“We measured IPC and IPF as a marker of increased platelet turnover [16] and found increased values 3 days after STEMI, consistent with previous findings [16].”
ResultSelf-citationLaboratory Markers of Platelet Production and Turnover
Bodrova, V. V., Shustova, O. N., Khaspekova, S. G., & Mazurov, A. V. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923140031 · Cited by 13
“Reticulated forms and size indicators”) was increased in the patients with ACS in comparison with the healthy donors [30, 78-80] and with the patients with stable angina [79].”
ResultMitani, N., Yujiri, T., Tanaka, Y., Tanaka, M., Fujii, Y., Hinoda, Y., & Tanizawa, Y. (2010) · Journal of Clinical Apheresis · doi:10.1002/jca.20275 · Cited by 12
“Several reports have shown an increase in the immature platelet count in patients with thrombotic disease without thrombocytosis [20]; with acute coronary syndromes, especially those in the acute phase of myocardial infarction [21]; and with neutrophilia and severe bacterial infection [22].”
BackgroundImpact of gender on immature platelet count and its relationship with coronary artery disease
the Novara Atherosclerosis Study Group (NAS), Negro, F., Verdoia, M., Tonon, F., Nardin, M., Kedhi, E., & Luca, G. D. (2020) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-020-02080-0 · Cited by 11
Hajeyah, A. A., Protty, M. B., Paul, D., Costa, D. O., Omidvar, N., Morgan, B., Iwasaki, Y., McGill, B., Jenkins, P. V., Yousef, Z. R., et al. (2023) · Journal of Lipid Research · doi:10.1016/j.jlr.2023.100484 · Cited by 13
Biomarkers in acute coronary artery disease
Freynhofer, M. K., Tajsić, M., Wojta, J., & Huber, K. (2012) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-012-0148-2 · Cited by 13
“Recent data have shown a significant association of reticulated platelets with coronary artery disease, especially with acute coronary syndromes [72].”
BackgroundWhy an aspirin a day no longer keeps the doctor away …
Lordkipanidzé, M. (2010) · Thrombosis and Haemostasis · doi:10.1160/th10-11-0749 · Cited by 11
“have already demonstrated that CAD patients have significantly higher levels of new, reactive platelets than healthy controls (11).”
BackgroundOppenheim, L., Loutati, R., Marmor, D. B., Perel, N., Tabi, M., Taha, L., Dvir, D., Shuvy, M., Jubeh, R., Glikson, M., et al. (2024) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/10760296241232852 · Cited by 10
“6,7 Increased IPF was reported in patients with arterial thrombotic events including ACS.”
BackgroundPedersen, O. B., Nissen, P. H., Pasalic, L., Hvas, A., Kristensen, S. D., & Grove, E. L. (2024) · Research and Practice in Thrombosis and Haemostasis · doi:10.1016/j.rpth.2024.102652 · Cited by 11
Self-citationImmature platelet fraction in cardiovascular diagnostics and antiplatelet therapy monitoring
Gumiężna, K., Baruś, P., Sygitowicz, G., Wiśniewska, A., Ochijewicz, D., Pasierb, K., Klimczak‐Tomaniak, D., Kuca‐Warnawin, E., Kochman, J., Grabowski, M., et al. (2023) · Cardiology Journal · doi:10.5603/cj.a2023.0019 · Cited by 11
“Further, it was observed that IPF levels were higher by 18% in smoking individuals, compared with non-smokers, and IPF was elevated by 16% in diabetics, compared with non-diabetics [18].”
BackgroundResultInfluentialImmature platelets and cardiovascular events in patients with stable coronary artery disease
Pedersen, O. B., Larsen, S. B., Kristensen, S. D., Hvas, A., & Grove, E. L. (2023) · Platelets · doi:10.1080/09537104.2023.2217960 · Cited by 9
“18 21 The CAD patients in this study were included at least one year after their most recent cardiovascular event and, overall, had markers of immature platelets within the reference intervals.”
BackgroundSelf-citationPedersen, O. B., Hvas, A., Pasalic, L., Kristensen, S. D., Grove, E. L., & Nissen, P. H. (2023) · Thrombosis and Haemostasis · doi:10.1055/s-0043-1776305 · Cited by 11
“41 As we obtained blood samples within the fi rst 24hours of admission, this mayexplainwhy the STEMI patients included in the present study had platelet maturity markers within the reference interval.”
MethodSelf-citationThe right oral antithrombotics in acute coronary syndromes
Grove, E. L., & Storey, R. F. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61961-9 · Cited by 9
Self-citationCan we improve the efficacy of low-dose aspirin?
Storey, R. F., Kristensen, S., & Grove, E. L. (2014) · Thrombosis and Haemostasis · doi:10.1160/th14-08-0702 · Cited by 9
“This should be investigated, but since platelet turnover is slightly higher in patients with coronary artery disease (25), one would expect that a similar – or even higher – benefit of bedtime aspirin dosing would be observed.”
BackgroundSelf-citationVerdoia, M., Nardin, M., Rolla, R., Pergolini, P., Suryapranata, H., Kedhi, E., Carriero, A., Luca, G. D., & Novara Atherosclerosis Study Group (NAS) (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3290 · Cited by 9
Godschalk, T. C., Byrne, R. A., Adriaenssens, T., Malik, N., Feldman, L. J., Guagliumi, G., Alfonso, F., Neumann, F., Trenk, D., Joner, M., et al. (2017) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2017.09.019 · Cited by 9
Gumiężna, K., Baruś, P., Sygitowicz, G., Wiśniewska, A., Bednarek, A., Zabłocki, J., Piasecki, A., Klimczak‐Tomaniak, D., Kochman, J., Grabowski, M., et al. (2024) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/10742484231202864 · Cited by 8
“13,14 To date, however, the long-term prognostic value of RPs or IPF quanti fi cation among patients presenting with ACS has not been elucidated.”
Impact of aging on immature platelet count and its relationship with coronary artery disease
Verdoia, M., Nardin, M., Negro, F., Tonon, F., Gioscia, R., Rolla, R., & Luca, G. D. (2020) · Platelets · doi:10.1080/09537104.2020.1714572 · Cited by 10
Reticulated platelets – clinical application and future perspectives
Meintker, L., & Krause, S. W. (2020) · Journal of Laboratory Medicine · doi:10.1515/labmed-2019-0166 · Cited by 12
Fracción de plaquetas inmaduras, un nuevo marcador pronóstico en el síndrome coronario agudo
López-Jiménez, R. A., Martín‐Herrero, F., González‐Porras, J. R., Sánchez‐Barba, M., Martín‐Luengo, C., & Pabón-Osuna, P. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2012.05.017 · Cited by 8
Immature platelet fraction in cardiology
Cao, Z., & Samarkhazan, H. S. (2025) · Clinica Chimica Acta · doi:10.1016/j.cca.2025.120600 · Cited by 6
Otani, T., Moriguchi‐Goto, S., Nishihira, K., Oguri, N., Shibata, Y., Matsuura, Y., Kodama, T., Asada, Y., Hatakeyama, K., & Yamashita, A. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.01.004 · Cited by 8
Hernández-Suárez, D. F., Nuñez-Medina, H., Scott, S. A., López‐Candales, A., Wiley, J. M., Garcia, M. J., Melín, K., Nieves-Borrero, K., Rodriguez-Ruiz, C., Marshall, L., et al. (2018) · Drug Metabolism and Personalized Therapy · doi:10.1515/dmpt-2017-0032 · Cited by 7
“It has been suggested that the reduced response to clopidogrel among patients with DM, resulting in HTPR, is due in part to a higher percentage of circulating immature platelets as well as to the loss of responsiveness to insulin [7, 24, 25].”
BackgroundPedersen, O. B., Pasalic, L., Grove, E. L., Kristensen, S. D., Hvas, A., & Nissen, P. H. (2023) · Methods and Protocols · doi:10.3390/mps6010008 · Cited by 7
Self-citationClopidogrel Bisulfate: A Review of its Use in the Management of Acute Coronary Syndrome
Rossini, R., Musumeci, G., Nijaradze, T., & Gavazzi, A. (2009) · Clinical Medicine Therapeutics · doi:10.4137/cmt.s1170 · Cited by 7
Rheumatoid arthritis: some components of hemostasis and inflammation
Cheldieva, F. A., & Reshetnyak, T. M. (2019) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2019-3-87-94 · Cited by 10
Pedersen, O. B., Hvas, A., Nissen, P. H., Pasalic, L., Kristensen, S. D., & Grove, E. L. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.03.028 · Cited by 6
Self-citationPlatelet count, platelet turnover and fibrin clot structure in patients with coronary artery disease
Neergaard‐Petersen, S., Hvas, A., Ajjan, R., Larsen, S. B., Würtz, M., Kristensen, S. D., & Grove, E. L. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.03.039 · Cited by 6
Self-citationSantos, M. T. B. R., Madrid, I., Moscardó, A., Latorre, A. M., Bonastre, J., Ruano, M., & Vallés, J. (2013) · Platelets · doi:10.3109/09537104.2013.816671 · Cited by 6
“elevated platelet turnover, which could provide a greater number of platelets with active COX1 [25] or COX2 [26], as the fraction of immature platelets is increased in AMI [27].”
BackgroundGiubilato, S., Leo, A., Cosentino, N., Fracassi, F., Cataneo, L., Porto, I., Leone, A. M., Burzotta, F., Trani, C., Biasucci, L. M., et al. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-09-0635 · Cited by 6
“Additionally, they previously demonstrated that immature platelet levels are increased in patients with ACS (51).”
BackgroundPrognostic Role of Platelet Reactivity in Patients With Acute Coronary Syndromes
Cavallari, I., Nusca, A., Ricottini, E., & Sciascio, G. D. (2014) · Cardiology in Review · doi:10.1097/crd.0000000000000034 · Cited by 7
“This may be due to massive activation and increased turnover of platelets in ACS patients, demonstrated by a significant elevation of immature cells fraction.(16) Recently, the results of another prospective study by Leé et al(17) have confirmed a higher baseline platelet reactivity in patients with myocardial infarct…”
ResultPlatelet and reticulocyte new parameters: why and how to use them?
Grotto, H. Z. W. (2016) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1016/j.bjhh.2016.08.001 · Cited by 6
Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment
Verdoia, M., Pergolini, P., Rolla, R., Suryapranata, H., Kedhi, E., & Luca, G. D. (2018) · Platelets · doi:10.1080/09537104.2018.1535707 · Cited by 6
Çanga, Y., Emre, A., Karataş, M. B., Çalık, A. N., Yelgeç, N. S., Yıldız, U., & Terzi, S. (2019) · Journal of Cardiovascular Emergencies · doi:10.2478/jce-2019-0008 · Cited by 6
Hosseini, E., Pezeshki, S. M. S., Ghasemzadeh, A., & Ghasemzadeh, M. (2025) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-025-03121-2 · Cited by 5
Toyoda, Y., Tateno, K., Takeda, Y., & Kobayashi, Y. (2021) · Platelets · doi:10.1080/09537104.2021.1983531 · Cited by 5
Regan, I. E., Cox, D., Kelleher, S. T., Nolan, B., Shaw, K., Smith, O. P., & McMahon, C. J. (2023) · Thrombosis Research · doi:10.1016/j.thromres.2023.11.014 · Cited by 5
Verdoia, M., Nardin, M., Negro, F., Rolla, R., Carriero, A., & Luca, G. D. (2019) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000786 · Cited by 5
Immature platelet fraction in rheumatoid arthritis with interstitial lung disease
Sargın, G., Yavaşoğlu, İ., & Şentürk, T. (2021) · Reumatología Clínica · doi:10.1016/j.reuma.2021.04.004 · Cited by 5
To Load or Not to Load? Aspirin Loading in Acute Ischemic Stroke: A Study of Clinical Outcomes
Su, T., Chan, Y., Lee, J.-D., Lee, M., Lin, L.-C., Wen, Y., & Lee, T. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.06.016 · Cited by 5
Bleeding and Clotting Disorders
Napeñas, J. J., & Patton, L. L. (2021) · Wiley eBooks · doi:10.1002/9781119597797.ch18 · Cited by 5
Lakkireddy, D. (2021) · Journal of Atrial Fibrillation · doi:10.4022/jafib.2459 · Cited by 5
Wang, Y., Chen, Y., & Zhang, T. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1087721 · Cited by 7
“Accession Sample source Organism Sample size Group Platform GSE59876 PBMCs H. sapiens 436 46 SCAD + 390 STEMI1 GPL62646 GSE62646 PBMCs H. sapiens 98 14 SCAD + 84 STEMI2 GPL62646 GSE123342 Whole blood H. sapiens 98 22 SCAD + 67 AMI GPL17586 GSE48060 Whole blood H. sapiens 52 21 NC + 31 AMI GPL570 GSE141512 PBMCs H. sap…”
BackgroundInfluentialVerdoia, M., Nardin, M., Negro, F., Rolla, R., & Luca, G. D. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.08.039 · Cited by 4
Loutati, R., Perel, N., Marmor, D. B., Maller, T., Taha, L., Amsalem, I., Hitter, R., Manassra, M., Levi, N., Shrem, M., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1333252 · Cited by 3
Immature Platelet Fraction and Acute Coronary Syndrome; a Systematic Review and Meta-Analysis.
Afshar, E. J., Shahnavaz, V., Talakoob, H., Kafialqora, P., Madady, A., Pourbahrighesmat, S., Tayebi, A., MozafaryBazargany, M., Gholami, N., Ayati, A., et al. (2024) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v12i1.2292 · Cited by 3
“In five studies there was a significant decreasing trend for IPF levels from STEMI to NSTEMI and UA patients, respectively[18, 19, 25, 28, 29]; however, no significant differences were found in the other two studies[21, 24].”
BackgroundMethodResultInfluentialPeriodic acid-Schiff (PAS) staining of immature platelets in donors
Pogorelov, V. M., Beskorovainova, V. J., Chanieva, M. I., Diagileva, O. A., Naumova, I. N., & Скедина, М. А. (2011) · Platelets · doi:10.3109/09537104.2011.589015 · Cited by 3
Reduced Effect of Aspirin and Clopidogrel Following Hybrid Coronary Revascularization
Modrau, I. S., Würtz, M., Kristensen, S. D., & Hvas, A. (2015) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/1076029615573304 · Cited by 3
Self-citationImmature platelet fraction in rheumatoid arthritis with interstitial lung disease
Sargın, G., Yavaşoğlu, İ., & Şentürk, T. (2022) · Reumatología Clínica (English Edition) · doi:10.1016/j.reumae.2021.04.010 · Cited by 3
Patrick, J., Johnson, A., Dillaha, L., & Pennell, A. T. (2016) · Future Cardiology · doi:10.2217/fca-2016-0042 · Cited by 3
The SH2B3 and KCNK5 loci may be implicated in regulation of platelet count, volume, and maturity
Christiansen, M. K., Larsen, S. B., Nyegaard, M., Neergaard‐Petersen, S., Würtz, M., Grove, E. L., Hvas, A., Jensen, H. K., & Kristensen, S. D. (2017) · Thrombosis Research · doi:10.1016/j.thromres.2017.08.009 · Cited by 3
Self-citationMPV and PDW as inflammatory indicators in chronic otitis media with effusion
Kepekçi, A. H. (2018) · Biomedical Research - India · doi:10.4066/biomedicalresearch.29-17-3364 · Cited by 3
“Platelet cytoplasmic granules contain several inflammatory products, including the Platelet Activation Factor (PAF), Platelet-Derived Growth Factor (PDGF), Platelet Factor-4 (PF4), beta-Thromboglobulin (bTg), Interleukin-1 (IL-1), leukotrienes, and prostaglandins [8,9].”
BackgroundANALYSIS OF IMMATURE PLATELET FRACTION AND MEAN PLATELET VOLUME IN ACUTE CORONARY SYNDROME PATIENT
Paramita, P., Nurulita, A., & Pakasi, R. D. (2019) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v25i3.1390 · Cited by 3
Evaluation of IPF counting on Mindray BC‐6800 hematology analyzer
Pecoraro, A., Troia, A., Sacco, M., Maggio, A., Marzo, R. D., & Gioia, M. (2016) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12524 · Cited by 3
“The usefulness of IPF determination is documented in thrombocytopenia diagnosis [1] and also in other pathologies such as: acute coronary syndrome which shows an increase in IPF values [4]; myelodysplastic syndromes where IPF rates >10% could be associated with a worse prognosis [5]; and sepsis as a biomarker for the…”
BackgroundMoschonas, I. C., & Tselepis, A. D. (2016) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248416662347 · Cited by 3
“Diabetic platelets are characterized by an increased turnover, that is, the increased rate of elimination and generation of newborn platelets in the circulation,(7,9,17) a proportion of which consists of immature platelets.(18) Another platelet disorder in T2DM is the heightened thromboxane A2 (TxA2) biosynthesis from…”
BackgroundImmature Platelet Fraction as A Potential Marker To Differentiate Types of Acute Coronary Syndrome
Indriastuti, E., Hernaningsih, Y., Indrasari, Y. N., & Andrianto, A. (2020) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v27i1.1609 · Cited by 2
Nardin, M., Verdoia, M., Negro, F., Tonon, F., & Luca, G. D. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.12.006 · Cited by 2
Stafylidis, C., Chatzidavid, S., Diamantopoulos, P. T., Vlachopoulou, D., Syriopoulou, S., Katsiampoura, P., Giannakopoulou, N., Pouliakis, A., Anastasopoulou, I., Κατσαρού, Ό., et al. (2024) · Thrombosis Research · doi:10.1016/j.thromres.2024.109211 · Cited by 2
Clinical significance of immature platelet fraction
Takami, A. (2010) · Japanese Journal of Thrombosis and Hemostasis · doi:10.2491/jjsth.21.547 · Cited by 2
Grove, E. L., Hvas, A., Larsen, S., MORTENSEN, S. B., & Kristensen, S. D. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04188.x · Cited by 2
Self-citationReticulated platelets – a new risk factor of atherothrombosis?
Khaspekova, S. G., Shustova, O. N., Bodrova, V. V., & Mazurov, A. V. (2021) · Aterotromboz = Atherothrombosis · doi:10.21518/2307-1109-2021-11-1-144-156 · Cited by 2
Amoah, V., Smallwood, A., Worrall, A. P., Lovatt, T. J., Armesilla, A. L., Nevill, A. M., & Cotton, J. M. (2011) · Thrombosis Research · doi:10.1016/j.thromres.2011.04.003 · Cited by 2
Effect of age on mean platelet volume: Does it exist?
Hoffmann, J. J. M. L., Nabbe, K. C., & van den Broek, N. M. A. (2015) · Experimental Gerontology · doi:10.1016/j.exger.2015.06.001 · Cited by 2
“Please cite this article as: Hoffmann, J.J.M.L., et al., Effect of age on mean p 10.1016/j.exger.2015.06.001 E D P R O O F (Grove et al., 2009).”
BackgroundInfluentialShadab, R., Kumar, T., Vijay, K., & Nath, R. K. (2023) · Journal of Cardiology and Cardiovascular Medicine · doi:10.29328/journal.jccm.1001163 · Cited by 1
“This is also comparable to the study done by Erik, et al. [26] which also showed a signi(cid:976)icant increase in IPF in ACS patients.”
ResultAllan, H. E., & Warner, T. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-96344-5_18 · Cited by 1
Duek, A., Zimin, A., Hershkop, Y., Cipok, M., Cohen, A., & Leiba, M. (2025) · Life · doi:10.3390/life15121846 · Cited by 1
“The IPF is measured using automated analyzers that utilize flow cytometry techniques and RNA-specific dyes to quantify these immature platelets [11,12].”
Acute Coronary Syndrome in Essential Thrombocythemia and Polycythemia Vera
Kaddoura, R., Ahmed, D., Rudwan, A., Elyas, A. A., & Yassin, M. A. (2025) · Heart Views · doi:10.4103/heartviews.heartviews_81_25 · Cited by 1
“[63] In stable CAD, increased platelet turnover could reduce the effect of aspirin, which may question the adequacy of a once-daily aspirin regimen in preventing platelet aggregation.”
Gene Polymorphism and Coronary Heart Disease
Dzimiri, N. (2012) · InTech eBooks · doi:10.5772/28590 · Cited by 1
“Thus, in women it appears to present more frequently with unstable angina and NSTEMI, whereas men will have ACS with STEMI 48-50 .”
BackgroundInfluentialEditor´s choice articles 2008–2009
Lip, G. Y. H., Preissner, K., & Weber, C. (2010) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1608916 · Cited by 1
Sarı, I. K., & Ceylan, S. (2022) · Experimental Biomedical Research · doi:10.30714/j-ebr.2022173856 · Cited by 1
“endothelium, and platelet cytoplasmic granules contain numerous inflammatory products, including leukotrienes, prostaglandins, plateletactivating factor, beta-thromboglobulin, and interleukin-1 [11-13].”
BackgroundKartal, B., & Şahiner, İ. T. (2023) · Cureus · doi:10.7759/cureus.44496 · Cited by 5
“The role of platelets in the context of inflammation-related disorders is now well-established within scientific discourse [12,13].”
BackgroundReticulated Platelets: A Promising Prognosis Marker in Cardiovascular Diseases
Esteve‐Pastor, M. A., Soler‐Espejo, E., & Marín, F. R. (2023) · Thrombosis and Haemostasis · doi:10.1055/a-2170-1892 · Cited by 1
Gumiężna, K., Bednarek, A., Sygitowicz, G., Baruś, P., Wiśniewska, A., Klimczak‐Tomaniak, D., Kochman, J., Opolski, G., Grabowski, M., & Tomaniak, M. (2023) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/177406 · Cited by 1
Platelet reactivity and antiplatelet management in diabetic patients with coronary artery disease
Proscia, C., Nusca, A., Mega, S., Melfi, R., & Sciascio, G. D. (2015) · Interventional Cardiology · doi:10.2217/ica.15.9 · Cited by 2
Grove, E. L., & Kristensen, S. D. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000085 · Cited by 1
Self-citationOfosu, F. A. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.11.025 · Cited by 1
Jiménez, M. M. (2010) · TDX (Tesis Doctorals en Xarxa)
Arbeláez, P. E. J., & Toro, P. A. A. (2013) · Universitas Médica · doi:10.11144/javeriana.umed54-4.iame
“conocido que las plaquetas son de menor tamaño [6,8,11,44,45].”
BackgroundWitasari, H. A., Pinzon, R. T., & Kristin, E. (2014) · Pharmaciana · doi:10.12928/pharmaciana.v4i2.1572
“Trombosit yang immature berpotensi meningkatkan haemostatik dan dapat menyebabkan pembentukan trombus (Grove et al, 2009).”
SKUTECZNO ZAPOBIEGANIA AKTYWACJI PËYTEK KRWI TOWARZYSZCEJ ANGIOPLASTYCE WIECOWEJ
Wachowiak, J. (2012)
Cardiac surgery and antiplatelet therapy
Malm, C. J. (2017) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Yun, K. H., & Cho, J. Y. (2017) · Korean Journal of Medicine · doi:10.3904/kjm.2017.92.6.526
“생성이나 급성관상동맥증후군 환자의 주요 심장 사건의 발 생과 연관이 있다고 한다[16-19].”
Should the Argument About Aspirin Dosing be About Frequency Rather the Dose?
Norgard, N. B., Jain, P., & Enriquez, J. R. (2019) · Frontiers in cardiovascular drug discovery · doi:10.2174/9781681083995119040003
A Potantiel Marker of in-Stentrestenosis: PDW/Platelet Ratio
Ekizler, F. A., & Çay, S. (2018) · Journal of Ankara University Faculty of Medicine · doi:10.4274/tipfak.76476
A Potantiel Marker of in-Stent Restenosis: Platelet Distribution Width/Platelet Ratio
Ekizler, F. A., & Çay, S. (2018) · Journal of Ankara University Faculty of Medicine · doi:10.4274/atfm.76476
Isparta ve çevresinde klopidogrel direncinin araştırılması
Aksoy, F., Baş, H. A., Bağcı, A., Uysal, B. A., Aksoy, S., Varol, E., & Altınbaş, A. (2019) · SDÜ Tıp Fakültesi Dergisi · doi:10.17343/sdutfd.507410
“Aynı zamanda diyabetes mellitusta dolaşımda immatür trombosit oranı artmıştır (20).”
Çoban, E., Xanmemmedov, E., & Soysal, A. (2015) · Turkish Journal of Cerebrovascular Diseases · doi:10.5505/tbdhd.2015.27146 · Cited by 1
Mulyadi, F., Prihatni, D., Rita, C., Turbawaty, D. K., & Astuti, A. (2020) · INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · doi:10.24293/ijcpml.v27i1.1633
(2009) · Circulation · doi:10.1161/circulationaha.109.192608
Association of immature platelets with perioperative complications in neurosurgery
Anetsberger, A., Bernlochner, I., Jungwirth, B., Blobner, M., Meyer, B., Kochs, E. F., Bongiovanni, D., Schmid, S., Langgartner, C., Baumgart, L., et al. (2023) · Platelets · doi:10.1080/09537104.2023.2185462
“While higher levels of immature platelets were observed in patients with acute coronary syndrome [18], data regarding the profile of RP in stroke are limited [19–22].”
BackgroundAnagrelide alleviates myocardial ischaemia–reperfusion injury by inhibiting reticulated platelets
Zhang, P., Xu, H., Zhao, X., Qi, Z., Yao, Y., Zhao, Q., Sun, P., Fan, B., Wu, H., & Ge, J. (2023) · Medical Hypotheses · doi:10.1016/j.mehy.2023.111193
Immature Platelet Fraction: A Promising Biomarker in Various Clinical Entities
Varghese, K. T. A. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr23322003335
Balti, D. R., Andrianto, A., Intan, R. E., & Alkaff, F. F. (2024) · Journal of the Pakistan Medical Association · doi:10.47391/jpma.s6-acsa-04 · Cited by 2
Panova‐Noeva, M. (2012) · Research Publications (Maastricht University) · doi:10.26481/dis.20121129mp
Zekanović, I., Marketin, T., Perić, M. M., Zekanović, D., Vulic, A., Miloš, M., Bogić, A., Marcinkovic, M., Pavlović, P. G., Antolic, M. R., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15031140
“IPF has shown prognostic relevance in cardiovascular and cerebrovascular disorders [17,18], but its role in myeloproliferative neoplasms as a marker of hypercoagulability is not completely understood.”
Lakmali, A., & Kulathilake, C. (2026) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-026-02373-0
Al-Hamashi, H. M. R., Almosawy, A. H. A. A., Omran, R. H., & Razak, F. S. A. (2026) · Лабораторная диагностика Восточная Европа · doi:10.34883/pi.2026.15.2.013
Grignano, M. A., Gregorini, M., Stea, E. D., Pattonieri, E. F., Soccio, G., Gentile, R., Albertini, R., Ciardelli, L. M., Russo, E., Rampino, T., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10753037/v1
Metadata
- Authors
- Hvas, A.-M., Kristensen, S. D., & Grove, E. L.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Grove, Erik Lerkevang
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2009
- Volume
- 101
- Issue
- 01
- Pages
- 151-153
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2127436599
- Cited by
- 202
- References
- 14
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 9 · 2023: 16 · 2022: 7 · 2021: 11 · 2020: 12 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 11 · 2015: 16 · 2014: 14 · 2013: 10 · 2012: 17
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Thrombosis and Haemostasis (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Danish Research Agency (2101–05–0052 to ELG and SDK)
- Topics
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- immature platelets, immature platelet fraction, acute coronary syndrome, stable coronary artery disease, acute myocardial infarction, unstable angina, platelet turnover, megakaryopoiesis, smoking, diabetes mellitus, coronary thrombus formation, hemostatic activity
- MeSH terms
- Adult, Aged, Aged, 80 and over, Angina, Unstable, Blood Platelets, Coronary Artery Disease, Coronary Thrombosis, Female, Flow Cytometry, Hemostasis, Humans, Male, Middle Aged, Myocardial Infarction, Platelet Count, Risk Factors, Linear Models, Case-Control Studies, Risk Assessment, Thrombopoiesis, Acute Coronary Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.